80
Views
0
CrossRef citations to date
0
Altmetric
Original Investigations

Assessing the impact of sex on high-frequency repetitive transcranial magnetic stimulation´s clinical response in schizophrenia – results from a secondary analysis

ORCID Icon, , , , , , , , , , , , , , , , , , , , & show all
Pages 233-241 | Received 17 Jan 2024, Accepted 03 Mar 2024, Published online: 01 May 2024

References

  • Aleman A, Enriquez-Geppert S, Knegtering H, Dlabac-de Lange JJ. 2018. Moderate effects of noninvasive brain stimulation of the frontal cortex for improving negative symptoms in schizophrenia: meta-analysis of controlled trials. Neurosci Biobehav Rev. 89:111–118. doi:10.1016/j.neubiorev.2018.02.009.
  • Brakemeier EL, Luborzewski A, Danker-Hopfe H, Kathmann N, Bajbouj M. 2007. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res. 41(5):395–403. doi:10.1016/j.jpsychires.2006.01.013.
  • Bundesärztekammer (BÄK) KBK, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). 2022. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Version 3.2.
  • Chan SKW, Chan HYV, Honer WG, Bastiampillai T, Suen YN, Yeung WS, Lam M, Lee WK, Ng RMK, Hui CLM, et al. 2021. Predictors of treatment-resistant and Clozapine-Resistant schizophrenia: a 12-Year follow-up study of first-Episode schizophrenia-Spectrum disorders. Schizophr Bull. 47(2):485–494. doi:10.1093/schbul/sbaa145.
  • Chung SW, Thomson CJ, Lee S, Worsley RN, Rogasch NC, Kulkarni J, Thomson RH, Fitzgerald PB, Segrave RA. 2019. The influence of endogenous estrogen on high-frequency prefrontal transcranial magnetic stimulation. Brain Stimul. 12(5):1271–1279. doi:10.1016/j.brs.2019.05.007.
  • Cordes J, Falkai P, Guse B, Hasan A, Schneider-Axmann T, Arends M, Winterer G, Wölwer W, Ben Sliman E, Ramacher M, et al. 2009. Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study. Eur Arch Psychiatry Clin Neurosci. 259 Suppl 2: s 189–197. doi:10.1007/s00406-009-0060-y.
  • Corp DT, Bereznicki HGK, Clark GM, Youssef GJ, Fried PJ, Jannati A, Davies CB, Gomes-Osman J, Kirkovski M, Albein-Urios N, et al. 2021. Large-scale analysis of interindividual variability in single and paired-pulse TMS data. Clin Neurophysiol. 132(10):2639–2653. doi:10.1016/j.clinph.2021.06.014.
  • Giordano GM, Bucci P, Mucci A, Pezzella P, Galderisi S. 2021. Gender differences in clinical and psychosocial features Among persons With schizophrenia: a mini review. Front Psychiatry. 12:789179. doi:10.3389/fpsyt.2021.789179.
  • Hanlon CA, McCalley DM. 2022. Sex/gender as a factor that influences transcranial magnetic stimulation treatment outcome: three potential biological explanations. Front Psychiatry. 13:869070. doi:10.3389/fpsyt.2022.869070.
  • Hansbauer M, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, et al. 2018. Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis. Psychiatry Res. 263:22–29. doi:10.1016/j.psychres.2018.02.030.
  • He H, Lu J, Yang L, Zheng J, Gao F, Zhai Y, Feng J, Fan Y, Ma X. 2017. Repetitive transcranial magnetic stimulation for treating the symptoms of schizophrenia: a PRISMA compliant meta-analysis. Clin Neurophysiol. 128(5):716–724. doi:10.1016/j.clinph.2017.02.007.
  • Herwig U, Schönfeldt-Lecuona C, Wunderlich AP, von Tiesenhausen C, Thielscher A, Walter H, Spitzer M. The navigation of transcranial magnetic stimulation. Psychiatry Res. 2001 Nov 30;108(2):123-31. doi: 10.1016/s0925-4927(01)00121-4. PMID: 11738546.
  • Herwig U, Satrapi P, Schönfeldt-Lecuona C. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 2003 Winter;16(2):95-9. doi: 10.1023/b:brat.0000006333.93597.9d. PMID: 14977202.
  • Homan 1987 reference: Homan RW, Herman J, Purdy P. Cerebral location of international 10-20 system electrode placement. Electroencephalogr Clin Neurophysiol. 1987 Apr;66(4):376–82. doi: 10.1016/0013-4694(87)90206-9. PMID: 2435517.
  • Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, et al. 2017. Treatment-Resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 174(3):216–229. doi:10.1176/appi.ajp.2016.16050503.
  • Huang CC, Wei IH, Chou YH, Su TP. 2008. Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression. Psychoneuroendocrinology. 33(6):821–831. doi:10.1016/j.psyneuen.2008.03.006.
  • Huber TJ, Schneider U, Rollnik J. 2003. Gender differences in the effect of repetitive transcranial magnetic stimulation in schizophrenia. Psychiatry Res. 120(1):103–105. doi:10.1016/s0165-1781(03)00170-7.
  • Ibáñez J, Spampinato DA, Paraneetharan V, Rothwell JC. 2020. SICI during changing brain states: differences in methodology can lead to different conclusions. Brain Stimul. 13(2):353–356. doi:10.1016/j.brs.2019.11.002.
  • Ilic TV, Jung P, Ziemann U. 2004. Subtle hemispheric asymmetry of motor cortical inhibitory tone. Clin Neurophysiol. 115(2):330–340. doi:10.1016/j.clinph.2003.09.017.
  • Ilić TV, Meintzschel F, Cleff U, Ruge D, Kessler KR, Ziemann U. 2002. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol. 545(1):153–167. doi:10.1113/jphysiol.2002.030122.
  • Jalinous R. 1991. Technical and practical aspects of magnetic nerve stimulation. J Clin Neurophysiol. 8(1):10–25. doi:10.1097/00004691-199101000-00004.
  • Kan RLD, Padberg F, Giron CG, Lin TTZ, Zhang BBB, Brunoni AR, Kranz GS. 2023. Effects of repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex on symptom domains in neuropsychiatric disorders: a systematic review and cross-diagnostic meta-analysis. Lancet Psychiatry. 10(4):252–259. doi:10.1016/S2215-0366(23)00026-3.
  • Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13(2):261–276. doi:10.1093/schbul/13.2.261.
  • Kedzior KK, Azorina V, Reitz SK. 2014. More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013. Neuropsychiatr Dis Treat. 10:727–756. doi:10.2147/NDT.S58405.
  • Kendrick T, Pilling S, Mavranezouli I, Megnin-Viggars O, Ruane C, Eadon H, Kapur N, Guideline C, Guideline Committee 2022. Management of depression in adults: summary of updated NICE guidance. BMJ. 378:o1557. doi:10.1136/bmj.o1557.
  • Krueger C, Tian L. A comparison of the general linear mixed model and repeated measures ANOVA using a dataset with multiple missing data points. Biol Res Nurs. 2004 Oct;6(2):151–7. doi: 10.1177/1099800404267682. PMID: 15388912.
  • Lefaucheur J-P, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, Filipović SR, Grefkes C, Hasan A, Hummel FC, et al. 2020. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018). Clin Neurophysiol. 131(2):474–528. doi:10.1016/j.clinph.2019.11.002.
  • Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J, American Psychiatric A, Steering Committee On PG, Steering Committee on Practice Guidelines 2004. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 161(2 Suppl):1–56.
  • Lisanby SH, Gutman D, Luber B, Schroeder C, Sackeim HA. 2001. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry. 49(5):460–463. doi:10.1016/s0006-3223(00)01110-0.
  • Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, Gilmer W, Marangell LB, Aaronson S, Daskalakis ZJ, et al. 2009. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 34(2):522–534. doi:10.1038/npp.2008.118.
  • Lorentzen R, Nguyen TD, McGirr A, Hieronymus F, Østergaard SD. 2022. The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis. Schizophrenia (Heidelb). 8(1):35. doi:10.1038/s41537-022-00248-6.
  • Maeda F, Gangitano M, Thall M, Pascual-Leone A. 2002. Inter- and intra-individual variability of paired-pulse curves with transcranial magnetic stimulation (TMS). Clin Neurophysiol. 113(3):376–382. doi:10.1016/s1388-2457(02)00008-1.
  • Maeda F, Keenan JP, Tormos JM, Topka H, Pascual-Leone A. 2000. Interindividual variability of the modulatory effects of repetitive transcranial magnetic stimulation on cortical excitability. Exp Brain Res. 133(4):425–430. doi:10.1007/s002210000432.
  • Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. 2012. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment. 2012:916198–916199. doi:10.1155/2012/916198.
  • Osoegawa C, Gomes JS, Grigolon RB, Brietzke E, Gadelha A, Lacerda ALT, Dias ÁM, Cordeiro Q, Laranjeira R, de Jesus D, et al. 2018. Non-invasive brain stimulation for negative symptoms in schizophrenia: an updated systematic review and meta-analysis. Schizophr Res. 197:34–44. doi:10.1016/j.schres.2018.01.010.
  • Richieri R, Boyer L, Farisse J, Colavolpe C, Mundler O, Lancon C, Guedj E. 2011. Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression. Eur J Nucl Med Mol Imaging. 38(9):1715–1722. doi:10.1007/s00259-011-1850-9.
  • Rostami R, Kazemi R, Nitsche MA, Gholipour F, Salehinejad MA. 2017. Clinical and demographic predictors of response to rTMS treatment in unipolar and bipolar depressive disorders. Clin Neurophysiol. 128(10):1961–1970. doi:10.1016/j.clinph.2017.07.395.
  • Sackeim HA, Aaronson ST, Carpenter LL, Hutton TM, Mina M, Pages K, Verdoliva S, West WS. 2020. Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation. J Affect Disord. 277:65–74. doi:10.1016/j.jad.2020.08.005.
  • Siskind D, Orr S, Sinha S, Yu O, Brijball B, Warren N, MacCabe JH, Smart SE, Kisely S. 2022. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis. Br J Psychiatry. 220(3):115–120. doi:10.1192/bjp.2021.61.
  • Stokes MG, Chambers CD, Gould IC, English T, McNaught E, McDonald O, Mattingley JB. 2007. Distance-adjusted motor threshold for transcranial magnetic stimulation. Clin Neurophysiol. 118(7):1617–1625. doi:10.1016/j.clinph.2007.04.004.
  • Tseng PT, Zeng BS, Hung CM, Liang CS, Stubbs B, Carvalho AF, Brunoni AR, Su KP, Tu YK, Wu YC, et al. 2022. Assessment of noninvasive brain stimulation interventions for negative symptoms of schizophrenia: a systematic review and network meta-analysis. JAMA Psychiatry. 79(8):770–779. doi:10.1001/jamapsychiatry.2022.1513.
  • Wang J, Zhou Y, Gan H, Pang J, Li H, Wang J, Li C. 2017. Efficacy Towards negative symptoms and safety of repetitive transcranial magnetic stimulation treatment for patients with schizophrenia: a systematic review. Shanghai Arch Psychiatry. 29(2):61–76.
  • Wobrock T, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, et al. 2015. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biol Psychiatry. 77(11):979–988. doi:10.1016/j.biopsych.2014.10.009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.